Buyout or takeover are the good thing for all AFFX investors. But without these deal we are still very good.
NSF got $7.5B for 2011 from Obama, NIH is look for $35B. It tells you there is more spending on research, more micro-array, more money into AFFX account.
Helicos is going to be delisted so why would anyone want to buy them? As an Affymetrix shareholder, I can say that Fodor has run this company into the ground. As such, any talk of a buyout is just plain BS.